{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,7]],"date-time":"2025-10-07T00:39:41Z","timestamp":1759797581191,"version":"build-2065373602"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,6]],"date-time":"2025-10-06T00:00:00Z","timestamp":1759708800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,10,6]],"date-time":"2025-10-06T00:00:00Z","timestamp":1759708800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"The 2023 Government-Funded Clinical Medicine Outstanding Talent Training Program","award":["ZF2023194"],"award-info":[{"award-number":["ZF2023194"]}]},{"name":"The 2018 Hebei Province Medical Science Research Key Project Plan","award":["20180018"],"award-info":[{"award-number":["20180018"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"DOI":"10.1186\/s12885-025-14775-9","type":"journal-article","created":{"date-parts":[[2025,10,6]],"date-time":"2025-10-06T12:45:07Z","timestamp":1759754707000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["NFKBIE as a prognostic biomarker and therapeutic target for GBM: role in Hedgehog signaling activation"],"prefix":"10.1186","volume":"25","author":[{"given":"Feng","family":"Mo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yang","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ce","family":"Dong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lijun","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoli","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Baogen","family":"Pan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhenzeng","family":"Fan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,10,6]]},"reference":[{"issue":"2","key":"14775_CR1","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1007\/s13311-017-0519-x","volume":"14","author":"R Chen","year":"2017","unstructured":"Chen R, Smith-Cohn M, Cohen AL, Colman H. Glioma subclassifications and their clinical significance. Neurotherapeutics. 2017;14(2):284\u201397.","journal-title":"Neurotherapeutics"},{"issue":"9","key":"14775_CR2","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1007\/s11864-020-00773-5","volume":"21","author":"AP Ghiaseddin","year":"2020","unstructured":"Ghiaseddin AP, Shin D, Melnick K, Tran DD. Tumor treating fields in the management of patients with malignant gliomas. Curr Treat Options Oncol. 2020;21(9):76.","journal-title":"Curr Treat Options Oncol"},{"issue":"12","key":"14775_CR3","doi-asserted-by":"publisher","first-page":"1438","DOI":"10.2174\/1568026617666170103162639","volume":"17","author":"KA Ghotme","year":"2017","unstructured":"Ghotme KA, Barreto GE, Echeverria V, Gonzalez J, Bustos RH, Sanchez M, Leszek J, Yarla NS, Gomez RM, Tarasov VV, et al. Gliomas: new perspectives in diagnosis, treatment and prognosis. Curr Top Med Chem. 2017;17(12):1438\u201347.","journal-title":"Curr Top Med Chem"},{"issue":"3","key":"14775_CR4","first-page":"209","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209\u201349.","journal-title":"CA Cancer J Clin"},{"key":"14775_CR5","doi-asserted-by":"crossref","unstructured":"\u015aledzi\u0144ska P, Bebyn MG, Furtak J, Kowalewski J, Lewandowska MA. Prognostic and predictive biomarkers in gliomas. Int J Mol Sci 2021, 22(19).","DOI":"10.3390\/ijms221910373"},{"issue":"5","key":"14775_CR6","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1007\/s11910-023-01265-3","volume":"23","author":"R Alshiekh Nasany","year":"2023","unstructured":"Alshiekh Nasany R, de la Fuente MI. Therapies for IDH-Mutant gliomas. Curr Neurol Neurosci Rep. 2023;23(5):225\u201333.","journal-title":"Curr Neurol Neurosci Rep"},{"issue":"7","key":"14775_CR7","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1038\/s41582-024-00967-7","volume":"20","author":"R Rud\u00e0","year":"2024","unstructured":"Rud\u00e0 R, Horbinski C, van den Bent M, Preusser M, Soffietti R. IDH Inhibition in gliomas: from preclinical models to clinical trials. Nat Rev Neurol. 2024;20(7):395\u2013407.","journal-title":"Nat Rev Neurol"},{"issue":"2","key":"14775_CR8","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1007\/s11060-020-03662-x","volume":"151","author":"L Poetsch","year":"2021","unstructured":"Poetsch L, Bronnimann C, Loiseau H, Fr\u00e9nel JS, Siegfried A, Seizeur R, Gauchotte G, Cappellen D, Carpentier C, Figarella-Branger D, et al. Characteristics of IDH-mutant gliomas with non-canonical IDH mutation. J Neurooncol. 2021;151(2):279\u201386.","journal-title":"J Neurooncol"},{"issue":"10","key":"14775_CR9","doi-asserted-by":"publisher","first-page":"1493","DOI":"10.1001\/jamaoncol.2022.2844","volume":"8","author":"TR Berger","year":"2022","unstructured":"Berger TR, Wen PY, Lang-Orsini M, Chukwueke UN. World health organization 2021 classification of central nervous system tumors and implications for therapy for Adult-Type gliomas: A review. JAMA Oncol. 2022;8(10):1493\u2013501.","journal-title":"JAMA Oncol"},{"issue":"6","key":"14775_CR10","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1097\/PPO.0b013e31818d8178","volume":"14","author":"G Cairncross","year":"2008","unstructured":"Cairncross G, Jenkins R. Gliomas with 1p\/19q codeletion: a.k.a. Oligodendroglioma. Cancer J. 2008;14(6):352\u20137.","journal-title":"Cancer J"},{"issue":"26","key":"14775_CR11","doi-asserted-by":"publisher","first-page":"2499","DOI":"10.1056\/NEJMoa1407279","volume":"372","author":"JE Eckel-Passow","year":"2015","unstructured":"Eckel-Passow JE, Lachance DH, Molinaro AM, Walsh KM, Decker PA, Sicotte H, Pekmezci M, Rice T, Kosel ML, Smirnov IV, et al. Glioma groups based on 1p\/19q, IDH, and TERT promoter mutations in tumors. N Engl J Med. 2015;372(26):2499\u2013508.","journal-title":"N Engl J Med"},{"issue":"12","key":"14775_CR12","first-page":"5636","volume":"27","author":"A Amato","year":"2023","unstructured":"Amato A, Imbimbo BP, Falsini B. Neurofibromatosis type 1-associated optic pathway gliomas: pathogenesis and emerging treatments. Eur Rev Med Pharmacol Sci. 2023;27(12):5636\u201353.","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"14775_CR13","doi-asserted-by":"crossref","unstructured":"Weller M, Wick W, Aldape K, Brada M, Berger M, Pfister SM, Nishikawa R, Rosenthal M, Wen PY, Stupp R et al. Glioma. Nat Rev Dis Primers 2015, 1:15017.","DOI":"10.1038\/nrdp.2015.17"},{"issue":"3","key":"14775_CR14","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1016\/S0369-8114(02)00289-4","volume":"50","author":"C Bottex-Gauthier","year":"2002","unstructured":"Bottex-Gauthier C, Pollet S, Favier A, Vidal DR. [The Rel\/NF-kappa-B transcription factors: complex role in cell regulation]. Pathol Biol (Paris). 2002;50(3):204\u201311.","journal-title":"Pathol Biol (Paris)"},{"issue":"23","key":"14775_CR15","doi-asserted-by":"publisher","first-page":"2666","DOI":"10.1182\/blood-2016-03-704528","volume":"128","author":"L Mansouri","year":"2016","unstructured":"Mansouri L, Noerenberg D, Young E, Mylonas E, Abdulla M, Frick M, Asmar F, Ljungstr\u00f6m V, Schneider M, Yoshida K, et al. Frequent NFKBIE deletions are associated with poor outcome in primary mediastinal B-cell lymphoma. Blood. 2016;128(23):2666\u201370.","journal-title":"Blood"},{"issue":"3","key":"14775_CR16","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1172\/JCI11991","volume":"107","author":"AS Baldwin","year":"2001","unstructured":"Baldwin AS. Control of oncogenesis and cancer therapy resistance by the transcription factor NF-kappaB. J Clin Invest. 2001;107(3):241\u20136.","journal-title":"J Clin Invest"},{"issue":"11","key":"14775_CR17","doi-asserted-by":"publisher","first-page":"7701","DOI":"10.1074\/jbc.C000916200","volume":"276","author":"WF Tam","year":"2001","unstructured":"Tam WF, Sen R. IkappaB family members function by different mechanisms. J Biol Chem. 2001;276(11):7701\u20134.","journal-title":"J Biol Chem"},{"issue":"6","key":"14775_CR18","doi-asserted-by":"publisher","first-page":"1287","DOI":"10.1038\/s41375-024-02236-4","volume":"38","author":"J Bordini","year":"2024","unstructured":"Bordini J, Lenzi C, Frenquelli M, Morabito A, Pseftogas A, Belloni D, Mansouri L, Tsiolas G, Perotta E, Ranghetti P, et al. I\u03baB\u03b5 deficiency accelerates disease development in chronic lymphocytic leukemia. Leukemia. 2024;38(6):1287\u201398.","journal-title":"Leukemia"},{"issue":"45","key":"14775_CR19","doi-asserted-by":"publisher","first-page":"15946","DOI":"10.1073\/pnas.1408552111","volume":"111","author":"Z Tao","year":"2014","unstructured":"Tao Z, Fusco A, Huang DB, Gupta K, Young Kim D, Ware CF, Van Duyne GD, Ghosh G. p100\/I\u03baB\u03b4 sequesters and inhibits NF-\u03baB through kappabsome formation. Proc Natl Acad Sci U S A. 2014;111(45):15946\u201351.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"6","key":"14775_CR20","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1084\/jem.20142009","volume":"212","author":"L Mansouri","year":"2015","unstructured":"Mansouri L, Sutton LA, Ljungstr\u00f6m V, Bondza S, Arng\u00e5rden L, Bhoi S, Larsson J, Cortese D, Kalushkova A, Plevova K, et al. Functional loss of I\u03baB\u03b5 leads to NF-\u03baB deregulation in aggressive chronic lymphocytic leukemia. J Exp Med. 2015;212(6):833\u201343.","journal-title":"J Exp Med"},{"issue":"4","key":"14775_CR21","doi-asserted-by":"publisher","first-page":"480","DOI":"10.3892\/ol.2024.14613","volume":"28","author":"Y Zhang","year":"2024","unstructured":"Zhang Y, Tu J, Wang J, Dai T, Zheng L, Sun S, Tu C, Li H, Qian L. NFKBIE is a predictive factor of survival and is correlated with immune infiltration and antigen processing and presentation in hepatocellular carcinoma. Oncol Lett. 2024;28(4):480.","journal-title":"Oncol Lett"},{"key":"14775_CR22","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.semcancer.2016.07.005","volume":"39","author":"L Mansouri","year":"2016","unstructured":"Mansouri L, Papakonstantinou N, Ntoufa S, Stamatopoulos K, Rosenquist R. NF-\u03baB activation in chronic lymphocytic leukemia: A point of convergence of external triggers and intrinsic lesions. Semin Cancer Biol. 2016;39:40\u20138.","journal-title":"Semin Cancer Biol"},{"issue":"1","key":"14775_CR23","first-page":"139","volume":"19","author":"RL Bowman","year":"2017","unstructured":"Bowman RL, Wang Q, Carro A, Verhaak RGW, Squatrito M. GlioVis data portal for visualization and analysis of brain tumor expression datasets. Neurooncology. 2017;19(1):139\u201341.","journal-title":"Neurooncology"},{"key":"14775_CR24","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/B978-0-12-802997-8.00005-0","volume":"134","author":"A Perry","year":"2016","unstructured":"Perry A, Wesseling P. Histologic classification of gliomas. Handb Clin Neurol. 2016;134:71\u201395.","journal-title":"Handb Clin Neurol"},{"issue":"7","key":"14775_CR25","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1038\/nrclinonc.2016.204","volume":"14","author":"G Reifenberger","year":"2017","unstructured":"Reifenberger G, Wirsching HG, Knobbe-Thomsen CB, Weller M. Advances in the molecular genetics of gliomas - implications for classification and therapy. Nat Rev Clin Oncol. 2017;14(7):434\u201352.","journal-title":"Nat Rev Clin Oncol"},{"key":"14775_CR26","doi-asserted-by":"publisher","first-page":"656908","DOI":"10.3389\/fimmu.2021.656908","volume":"12","author":"D Laha","year":"2021","unstructured":"Laha D, Grant R, Mishra P, Nilubol N. The role of tumor necrosis factor in manipulating the immunological response of tumor microenvironment. Front Immunol. 2021;12:656908.","journal-title":"Front Immunol"},{"issue":"3","key":"14775_CR27","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1016\/S0002-9440(10)62048-2","volume":"167","author":"AM Khatib","year":"2005","unstructured":"Khatib AM, Auguste P, Fallavollita L, Wang N, Samani A, Kontogiannea M, Meterissian S, Brodt P. Characterization of the host Proinflammatory response to tumor cells during the initial stages of liver metastasis. Am J Pathol. 2005;167(3):749\u201359.","journal-title":"Am J Pathol"},{"key":"14775_CR28","doi-asserted-by":"publisher","first-page":"1190333","DOI":"10.3389\/fimmu.2023.1190333","volume":"14","author":"J Han","year":"2023","unstructured":"Han J, Wu M, Liu Z. Dysregulation in IFN-\u03b3 signaling and response: the barricade to tumor immunotherapy. Front Immunol. 2023;14:1190333.","journal-title":"Front Immunol"},{"issue":"7","key":"14775_CR29","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1084\/jem.20041463","volume":"201","author":"JK Whitmire","year":"2005","unstructured":"Whitmire JK, Tan JT, Whitton JL. Interferon-gamma acts directly on CD8\u2009+\u2009T cells to increase their abundance during virus infection. J Exp Med. 2005;201(7):1053\u20139.","journal-title":"J Exp Med"},{"issue":"3","key":"14775_CR30","first-page":"16","volume":"33","author":"DJ Salih","year":"2025","unstructured":"Salih DJ, Barsoom SH, Ahmed GF, Hussien SQ, Al Ismaeel Q, Alasady AAB, Alsalim TA, Salih AM. Curcumin inhibits IFN-\u03b3 induced PD-L1 expression via reduction of STAT1 phosphorylation in A549 non-small cell lung cancer cells. Saudi Pharm Journal: SPJ : Official Publication Saudi Pharm Soc. 2025;33(3):16.","journal-title":"Saudi Pharm Journal: SPJ : Official Publication Saudi Pharm Soc"},{"key":"14775_CR31","doi-asserted-by":"crossref","unstructured":"Shen SC, Dey S, DuHadaway JB, Sutanto-Ward E, Hampton MT, Kozlov SV, Prendergast GC, Muller AJ. Neovascular pruning by IDO1 inhibitors can potentiate Immunogenic cytotoxicity of ischemia-targeted agents to synergistically enhance anti-PD-1 responsiveness. J Immunother Cancer 2025, 13(5).","DOI":"10.1136\/jitc-2024-011398"},{"issue":"5","key":"14775_CR32","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1016\/j.stem.2024.04.004","volume":"31","author":"JJ Loh","year":"2024","unstructured":"Loh JJ, Ma S. Hallmarks of cancer stemness. Cell Stem Cell. 2024;31(5):617\u201339.","journal-title":"Cell Stem Cell"},{"key":"14775_CR33","doi-asserted-by":"publisher","first-page":"921975","DOI":"10.3389\/fonc.2022.921975","volume":"12","author":"X Wang","year":"2022","unstructured":"Wang X, Liang J, Sun H. The network of tumor microtubes: an improperly reactivated neural cell network with stemness feature for resistance and recurrence in gliomas. Front Oncol. 2022;12:921975.","journal-title":"Front Oncol"},{"key":"14775_CR34","doi-asserted-by":"crossref","unstructured":"Biserova K, Jakovlevs A, Uljanovs R, Strumfa I. Cancer stem cells: significance in origin, pathogenesis and treatment of glioblastoma. Cells 2021, 10(3).","DOI":"10.3390\/cells10030621"},{"key":"14775_CR35","doi-asserted-by":"publisher","first-page":"1280","DOI":"10.3389\/fimmu.2020.01280","volume":"11","author":"L Walcher","year":"2020","unstructured":"Walcher L, Kistenmacher AK, Suo H, Kitte R, Dluczek S, Strau\u00df A, Blaudszun AR, Yevsa T, Fricke S, Kossatz-Boehlert U. Cancer stem Cells-Origins and biomarkers: perspectives for targeted personalized therapies. Front Immunol. 2020;11:1280.","journal-title":"Front Immunol"},{"key":"14775_CR36","doi-asserted-by":"publisher","first-page":"155227","DOI":"10.1016\/j.prp.2024.155227","volume":"256","author":"A Gholamzad","year":"2024","unstructured":"Gholamzad A, Khakpour N, Khosroshahi EM, Asadi S, Koohpar ZK, Matinahmadi A, Jebali A, Rashidi M, Hashemi M, Sadi FH, et al. Cancer stem cells: the important role of CD markers, signaling pathways, and MicroRNAs. Pathol - Res Pract. 2024;256:155227.","journal-title":"Pathol - Res Pract"},{"key":"14775_CR37","doi-asserted-by":"crossref","unstructured":"Robinson M, Gilbert SF, Waters JA, Lujano-Olazaba O, Lara J, Alexander LJ, Green SE, Burkeen GA, Patrus O, Sarwar Z et al. Characterization of SOX2, OCT4 and NANOG in ovarian cancer Tumor-Initiating cells. Cancers 2021, 13(2).","DOI":"10.3390\/cancers13020262"},{"issue":"1","key":"14775_CR38","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1038\/s41392-020-0134-x","volume":"5","author":"J Fares","year":"2020","unstructured":"Fares J, Fares MY, Khachfe HH, Salhab HA, Fares Y. Molecular principles of metastasis: a hallmark of cancer revisited. Signal Transduct Target Ther. 2020;5(1):28.","journal-title":"Signal Transduct Target Ther"},{"issue":"6","key":"14775_CR39","doi-asserted-by":"publisher","first-page":"e431","DOI":"10.1002\/mco2.431","volume":"4","author":"YL Lan","year":"2023","unstructured":"Lan YL, Zou S, Wang W, Chen Q, Zhu Y. Progress in cancer neuroscience. MedComm (2020). 2023;4(6):e431.","journal-title":"MedComm (2020)"},{"key":"14775_CR40","doi-asserted-by":"crossref","unstructured":"De Fazio E, Pittarello M, Gans A, Ghosh B, Slika H, Alimonti P, Tyler B. Intrinsic and microenvironmental drivers of glioblastoma invasion. Int J Mol Sci 2024, 25(5).","DOI":"10.3390\/ijms25052563"},{"key":"14775_CR41","doi-asserted-by":"crossref","unstructured":"Loh CY, Chai JY, Tang TF, Wong WF, Sethi G, Shanmugam MK, Chong PP, Looi CY. The E-Cadherin and N-Cadherin Switch in Epithelial-to-Mesenchymal Transition: Signaling, Therapeutic Implications, and Challenges. Cells 2019, 8(10).","DOI":"10.3390\/cells8101118"},{"issue":"2","key":"14775_CR42","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1016\/j.ejogrb.2008.01.004","volume":"139","author":"R Shaco-Levy","year":"2008","unstructured":"Shaco-Levy R, Sharabi S, Benharroch D, Piura B, Sion-Vardy N. Matrix metalloproteinases 2 and 9, E-cadherin, and \u03b2-catenin expression in endometriosis, low-grade endometrial carcinoma and non-neoplastic eutopic endometrium. Eur J Obstet Gynecol Reproductive Biology. 2008;139(2):226\u201332.","journal-title":"Eur J Obstet Gynecol Reproductive Biology"},{"issue":"1","key":"14775_CR43","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1186\/1756-9966-30-87","volume":"30","author":"RS Wong","year":"2011","unstructured":"Wong RS. Apoptosis in cancer: from pathogenesis to treatment. J Exp Clin Cancer Res. 2011;30(1):87.","journal-title":"J Exp Clin Cancer Res"},{"key":"14775_CR44","doi-asserted-by":"crossref","unstructured":"Morana O, Wood W, Gregory CD. The apoptosis paradox in cancer. Int J Mol Sci 2022, 23(3).","DOI":"10.3390\/ijms23031328"},{"issue":"6","key":"14775_CR45","doi-asserted-by":"publisher","first-page":"5397","DOI":"10.3390\/cimb46060323","volume":"46","author":"C Berrino","year":"2024","unstructured":"Berrino C, Omar A. Unravelling the mysteries of the Sonic Hedgehog pathway in cancer stem cells: activity, crosstalk and regulation. Curr Issues Mol Biol. 2024;46(6):5397\u2013419.","journal-title":"Curr Issues Mol Biol"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-025-14775-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12885-025-14775-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-025-14775-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,6]],"date-time":"2025-10-06T12:45:10Z","timestamp":1759754710000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/s12885-025-14775-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,6]]},"references-count":45,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["14775"],"URL":"https:\/\/doi.org\/10.1186\/s12885-025-14775-9","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,6]]},"assertion":[{"value":"3 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethics approval for this study was obtained from the Medical Ethics Committee of Hebei General Hospital (Approval No. 2024-WD-96). All procedures involving animals were conducted in accordance with the guidelines for the care and use of laboratory animals. For mouse euthanasia, we used carbon dioxide inhalation. Mice were placed in a chamber with a gradual increase in CO\u2082 concentration, which induced unconsciousness and then death, ensuring humane and pain - free euthanasia in line with ethical guidelines.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1512"}}